Mark Ragosa

CHIEF FINANCIAL OFFICER

Mark Ragosa (CHIEF FINANCIAL OFFICER) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $1.8M of KNSA (42,841 sh × $41.49, as filed), executed Dec 8 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.6M

shares × price, as filed

Last traded

Mar 9

Filed Mar 11

Median ADV $60.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $11.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 13 sells 13 filings

Recent filings

KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.7M
36,722 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $772K
17,845 sh across 2 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $503K
12,000 sh × $41.89
Exec Jan 8
Filed Jan 9 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.8M
42,841 sh × $41.49
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $815K
19,900 sh × $40.94
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $621K
18,889 sh × $32.89
Exec Aug 4 2025
Filed Aug 6 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $527K
18,299 sh × $28.80
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.3M
88,395 sh across 3 lots
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET More filings →